Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7,227,333
-
Total 13F shares
-
9,173,287
-
Share change
-
-375,981
-
Total reported value
-
$36,785,829
-
Price per share
-
$4.01
-
Number of holders
-
54
-
Value change
-
-$692,653
-
Number of buys
-
28
-
Number of sells
-
23
Institutional Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q4 2019
As of 31 Dec 2019,
Kezar Life Sciences Inc - COMMON-STOCK (KZR) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,173,287 shares.
The largest 10 holders included
FMR LLC, Bellevue Group AG, BlackRock Inc., VICTORY CAPITAL MANAGEMENT INC, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, Prosight Management, LP, STATE STREET CORP, CHI Advisors LLC, and NORTHERN TRUST CORP.
This page lists
54
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.